Evidence map›Paper›PMID 41855153›Full record

ArticlePloS one2026

Enhancing second harmonic generation-mediated photodynamic therapy via external electric field modulation.

Manu Kumar, Avinash Jukanti, Rivka Cahan, Dima Cheskis, Refael Minnes

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manu KumarDepartment of Physics, Faculty of Natural Sciences, Ariel University, Ariel, Israel.
Avinash JukantiDepartment of Chemical Engineering, Ariel University, Ariel, Israel.
Rivka CahanDepartment of Chemical Engineering, Ariel University, Ariel, Israel.
Dima CheskisDepartment of Physics, Faculty of Natural Sciences, Ariel University, Ariel, Israel.
Refael MinnesDepartment of Physics, Faculty of Natural Sciences, Ariel University, Ariel, Israel.ORCID https://orcid.org/0000-0002-1857-4905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) utilizes light-activated photosensitizers (PS) to produce reactive oxygen species (ROS) for targeted bacterial destruction; however, its efficacy is often limited by inadequate light penetration, necessitating novel enhancements, such as the integration of second harmonic generation (SHG) through harmonic nanoparticles (HNPs) that convert two photons into one of higher frequency, thereby advancing the approach of SHG-based PDT for improved bacterial eradication. Our novel technique explores the impact of an e (EEF) on SHG intensity to augment PDT efficacy against Staphylococcus aureus (S. aureus). We investigated a novel conjugate, Bismuth Ferrite (BFO) in conjunction with protoporphyrin IX (PPIX), and compared it to the Barium Titanate (BT)-PPIX conjugate, under EEF of 0 V, 10 V, and 20 V for a duration of 5 minutes. The experiments utilized a near-infrared (NIR) femtosecond pulsed laser at 798 nm for excitation. Our findings show that EEF significantly enhances SHG intensity, improving photodynamic activity. Notably, BFO-PPIX conjugates significantly decreased bacterial survival to 35.8 ± 3.0% under EEF exposure, in contrast to 48.1 ± 3.2% without EEF. Similarly, to further substantiate the impact of EEF on SHG-based PDT efficacy, BT-PPIX conjugates resulted in bacterial survival of 57.1 ± 1.0% with EEF exposure, in contrast to 78.4 ± 3.7% without EEF. Our findings confirm the first study of EEF-modulated SHG in PDT, demonstrating its capacity to augment SHG intensity in HNPs-PPIX conjugates and improve therapeutic efficacy. These results highlight the potential of SHG-enhanced PDT, particularly with optimized EEF.

Indexed as

PhotochemotherapyPhotosensitizing AgentsBismuthFerric CompoundsProtoporphyrinsReactive Oxygen SpeciesStaphylococcus aureusBismuthFerric CompoundsferritePhotosensitizing Agentsprotoporphyrin IXProtoporphyrinsReactive Oxygen Species

Identifiers

PMID41855153
PMCPMC13001933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.